scispace - formally typeset
J

J. Wade Harper

Researcher at Harvard University

Publications -  292
Citations -  75309

J. Wade Harper is an academic researcher from Harvard University. The author has contributed to research in topics: Ubiquitin ligase & Ubiquitin. The author has an hindex of 109, co-authored 279 publications receiving 66267 citations. Previous affiliations of J. Wade Harper include University of Wisconsin-Madison & Institute of Cancer Research.

Papers
More filters
Journal ArticleDOI

Expression of Met-(−1) angiogenin in Escherichia coli: conversion to the authentic <Glu-1 protein

TL;DR: Conversion of Met-(-1) angiogenin to the authentic less than Glu-1 protein was achieved by treatment with Aeromonas aminopeptidase under conditions in which the new N-terminal glutamine readily cyclizes nonenzymatically.
Journal ArticleDOI

Structural conservation of distinctive N-terminal acetylation-dependent interactions across a family of mammalian NEDD8 ligation enzymes

TL;DR: Distinct preferences of UBC12 and UBE2F peptides for inhibiting different DCNLs, including the oncogenic DCNL1 protein, suggest it may be possible to develop small molecules blocking specific N-acetyl-methionine-dependent protein interactions.
Journal ArticleDOI

The oncoprotein kinase chaperone CDC37 functions as an oncogene in mice and collaborates with both c-myc and cyclin D1 in transformation of multiple tissues.

TL;DR: It is reported that mouse mammary tumor virus (MMTV)-CDC37 transgenic mice develop mammary gland tumors at a rate comparable to that observed previously in MMTV-cyclin D1 mice, and suggests that the establishment of protein kinase pathways mediated by Cdc37-Hsp90 can be a rate-limiting event in epithelial cell transformation.
Journal ArticleDOI

HiNF-P directly links the cyclin E/CDK2/p220NPAT pathway to histone H4 gene regulation at the G1/S phase cell cycle transition.

TL;DR: It is demonstrated that HiNF-P, a transcriptional regulator of replication-dependent histone H4 genes, interacts directly with p220NPAT, a substrate of cyclin E/CDK2, to coactivate histone genes during S phase.